Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients
Clinical trial NCT02826486 · COMPLETED
Trial details
- NCT number
- NCT02826486
- Sponsor
- BioLineRx, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2022-09-06
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.